BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 32387456)

  • 1. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
    Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
    Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.
    Jiménez-Alcaide E; García-Fuentes C; Hernández V; De la Peña E; Pérez-Fernández E; Castro A; Caballero-Perea B; Guijarro A; Llorente C
    Prostate; 2021 Dec; 81(16):1349-1354. PubMed ID: 34517429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and androgen-targeted therapy for prostate cancer patients.
    Bhowmick NA; Oft J; Dorff T; Pal S; Agarwal N; Figlin RA; Posadas EM; Freedland SJ; Gong J
    Endocr Relat Cancer; 2020 Sep; 27(9):R281-R292. PubMed ID: 32508311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can androgen deprivation therapy play a protective role in SARS-CoV-infections?].
    Schlack K; Krabbe LM
    Urologe A; 2020 Oct; 59(10):1251-1253. PubMed ID: 32776230
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis.
    Sari Motlagh R; Abufaraj M; Karakiewicz PI; Rajwa P; Mori K; Mun DH; Shariat SF
    World J Urol; 2022 Apr; 40(4):907-914. PubMed ID: 34477955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.
    Caffo O; Zagonel V; Baldessari C; Berruti A; Bortolus R; Buti S; Ceresoli GL; Donini M; Ermacora P; Fornarini G; Fratino L; Masini C; Massari F; Mosca A; Mucciarini C; Procopio G; Tucci M; Verri E; Zucali P; Buttigliero C
    Ann Oncol; 2020 Oct; 31(10):1415-1416. PubMed ID: 32562741
    [No Abstract]   [Full Text] [Related]  

  • 7. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
    Schmidt AL; Tucker MD; Bakouny Z; Labaki C; Hsu CY; Shyr Y; Armstrong AJ; Beer TM; Bijjula RR; Bilen MA; Connell CF; Dawsey SJ; Faller B; Gao X; Gartrell BA; Gill D; Gulati S; Halabi S; Hwang C; Joshi M; Khaki AR; Menon H; Morris MJ; Puc M; Russell KB; Shah NJ; Sharifi N; Shaya J; Schweizer MT; Steinharter J; Wulff-Burchfield EM; Xu W; Zhu J; Mishra S; Grivas P; Rini BI; Warner JL; Zhang T; Choueiri TK; Gupta S; McKay RR
    JAMA Netw Open; 2021 Nov; 4(11):e2134330. PubMed ID: 34767021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen deprivation therapy in men with prostate cancer is not associated with COVID-2019 infection.
    Davidsson S; Messing Eriksson A; Udumyan R; Swanholm P; Lewin Lundh M; Widing C; Lindlöf C; Fridfeldt J; Andersson SO; Fall K
    Prostate; 2023 May; 83(6):555-562. PubMed ID: 36658755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2.
    Klein EA; Li J; Milinovich A; Schold JD; Sharifi N; Kattan MW; Jehi L
    J Urol; 2021 Feb; 205(2):441-443. PubMed ID: 32897764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and The Prostate Cancer Connection.
    Gomella LG
    Can J Urol; 2020 Oct; 27(5):10346. PubMed ID: 33049184
    [No Abstract]   [Full Text] [Related]  

  • 11. Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic.
    Zuliani S; Zampiva I; Tregnago D; Casali M; Cavaliere A; Fumagalli A; Merler S; Riva ST; Rossi A; Zacchi F; Zaninotto E; Auriemma A; Pavarana M; Soldà C; Benini L; Borghesani M; Caldart A; Casalino S; Gaule M; Kadrija D; Mongillo M; Pesoni C; Biondani P; Cingarlini S; Fiorio E; Melisi D; Parolin V; Tondulli L; Belluomini L; Zecchetto C; Avesani B; Biasi A; Bovo C; Dazzani E; Dodi A; Gelmini S; Leta LC; Lo Cascio G; Lombardo F; Lucin E; Martinelli IA; Messineo L; Moscarda V; Pafumi S; Reni A; Sartori G; Scaglione IM; Shoval Y; Sposito M; Tacconelli E; Trestini I; Zambonin V; Zanelli S; Pilotto S; Milella M
    Eur J Cancer; 2020 Aug; 135():159-169. PubMed ID: 32580131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen deprivation and SARS-CoV-2 in men with prostate cancer.
    Koskinen M; Carpen O; Honkanen V; Seppänen MRJ; Miettinen PJ; Tuominen JA; Raivio T
    Ann Oncol; 2020 Oct; 31(10):1417-1418. PubMed ID: 32615154
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting TMPRSS2 in SARS-CoV-2 Infection.
    Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
    Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between COVID-19 and prostate cancer.
    Bahmad HF; Abou-Kheir W
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):561-563. PubMed ID: 32709978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?
    Fantin JPP; Facio MFW; Spessoto ACN; Spessoto LCF; Facio Junior FN
    Rev Assoc Med Bras (1992); 2020 Oct; 66(10):1314-1315. PubMed ID: 33174915
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional COVID-19 Network for Coordination of SARS-CoV-2 outbreak in Veneto, Italy.
    Pasin L; Sella N; Correale C; Boscolo A; Rosi P; Saia M; Mantoan D; Navalesi P
    J Cardiothorac Vasc Anesth; 2020 Sep; 34(9):2341-2345. PubMed ID: 32425461
    [No Abstract]   [Full Text] [Related]  

  • 17. [A few hints to face Covid-19 pandemic in Italy].
    Vener C; Ambrogi F; Sant M; Pravettoni G
    Epidemiol Prev; 2020; 44(4):201. PubMed ID: 32921023
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.
    Sean Ong XR; Condon B; Bagguley D; Lawrentschuk N; Azad A; Murphy D
    Future Oncol; 2020 Jul; 16(20):1409-1411. PubMed ID: 32407145
    [No Abstract]   [Full Text] [Related]  

  • 19. Health Surveillance and Response to SARS-CoV-2 Mass Testing in Health Workers of a Large Italian Hospital in Verona, Veneto.
    Porru S; Carta A; Monaco MGL; Verlato G; Battaggia A; Parpaiola M; Lo Cascio G; Pegoraro M; Militello V; Moretti F; Tardivo S
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32679773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.